MorphoSys AG ADR Financials

Based on the key indicators related to MorphoSys' liquidity, profitability, solvency, and operating efficiency, MorphoSys AG ADR is not in a good financial situation at the moment. It has a very high risk of going through financial straits in October.
  
Understanding current and past MorphoSys Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of MorphoSys' financial statements are interrelated, with each one affecting the others. For example, an increase in MorphoSys' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in MorphoSys' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MorphoSys AG ADR. Check MorphoSys' Beneish M Score to see the likelihood of MorphoSys' management manipulating its earnings.

MorphoSys Stock Summary

MorphoSys competes with Century Therapeutics, Edgewise Therapeutics, C4 Therapeutics, Mineralys Therapeutics,, and Cullinan Oncology. MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. The company was founded in 1992 and is headquartered in Planegg, Germany. Morphosys operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 648 people.
Foreign Associate
  Germany
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS6177602025
Business AddressSemmelweisstrasse 7, Planegg,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.morphosys.com
Phone49 89 899 27 0
CurrencyUSD - US Dollar

MorphoSys Key Financial Ratios

There are many critical financial ratios that MorphoSys' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that MorphoSys AG ADR reports annually and quarterly.

MorphoSys Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining MorphoSys's current stock value. Our valuation model uses many indicators to compare MorphoSys value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MorphoSys competition to find correlations between indicators driving MorphoSys's intrinsic value. More Info.
MorphoSys AG ADR is rated below average in return on equity category among its peers. It is regarded third in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value MorphoSys by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

MorphoSys Market Pulse

 Quote0.0
 Change(%) 0.00  
 Change0.00 
 Open0.0
 Low0.0
 High0.0
 Volume1
 ExchangeNASDAQ

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as MorphoSys is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of MorphoSys has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if MorphoSys' financials are consistent with your investment objective using the following steps:
  • Review MorphoSys' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand MorphoSys' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare MorphoSys' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if MorphoSys' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

MorphoSys September 19, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of MorphoSys help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MorphoSys AG ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of MorphoSys AG ADR based on widely used predictive technical indicators. In general, we focus on analyzing MorphoSys Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MorphoSys's daily price indicators and compare them against related drivers.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in MorphoSys Stock

If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences